Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma

Clinical Trial ID NCT00294632

Rank	Title	Journal	Year	PubWeight™‹?›
1	Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.	Lancet Oncol	2012	2.25